Loading
Invitae
Invitae was a large US genetic testing company, used by many families to check for inherited changes that raise cancer risk. It went bankrupt in 2024 and Labcorp bought its main business; its tests are now sold as part of Labcorp.
Also called: Invitae CorporationInvitae Corp
Overview
Invitae, based in San Francisco, described itself as a medical genetics company delivering genetic information to patients and their providers through digital technology, with testing across oncology, women's health, paediatric and rare disease, cardiology and neurology. On 13 February 2024 Invitae (then OTC: NVTA) filed for voluntary Chapter 11 protection in the US Bankruptcy Court for the District of New Jersey, with the support of its senior secured noteholders, to pursue a sale. On 5 August 2024 Labcorp announced it had completed the acquisition of select assets of Invitae (OTC: NVTAQ), to expand its specialty testing in oncology and rare disease. The Invitae website now operates under Labcorp.
Headquarters
San Francisco, CA, US
Funding
All startupsAcquiredAcquired by Labcorp
Type
Stage
Acquired
Website
Notes
- Neither the Invitae bankruptcy release nor the Labcorp completion release states a purchase price, so none is recorded. Labcorp bought select assets rather than the corporation as a whole. Founding year and former exchange listing are not recorded because no source read here states them. Invitae's own cancer test menu was not read.
Connected
5Similar pages
- JournalFamilial cancer
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
- CollectionFORCE: Facing Our Risk of Cancer Empowered
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
- TermWilms tumour risk markers (anaplasia, 1p/16q loss, 1q gain, SIOP and COG risk groups)
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
- PersonGilda Radner
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
- Key paperWhole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
- TermMEN1 and hereditary neuroendocrine syndromes
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
- InstitutionHospital de Clínicas de Porto Alegre
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
- CancerFumarate hydratase-deficient renal cell carcinoma (HLRCC-associated)
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
fronts
technologies
companies
terms
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
invitae.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/